SCHEMBL6584574

SCHEMBL6584574

O=S(=O)(Oc1cc(C(F)(F)F)ccc1Cl)C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 1/20 0.43
TSHR P16473 1/20 0.43
KMT2A Q03164 1/20 0.43
ATM Q13315 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MCL1 Q07820 5/20 0.42
MRGPRX4 Q96LA9 2/20 0.40
EPAS1 Q99814 1/20 0.40
ALK Q9UM73 1/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPT P10636 1/20 0.39
USP2 O75604 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
HSD11B1 P28845 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8500197 0.83 EPAS1 (0.40) ALDH1A1MCL1MRGPRX4EPAS1HSD11B1
SCHEMBL7597732 0.81 CES2 (0.43) ALDH1A1KMT2AEPAS1KDM4EUSP2
SCHEMBL28741529 0.81 EPAS1 (0.41) ALDH1A1MEN1KMT2AMRGPRX4EPAS1
SCHEMBL12035597 0.80 EPAS1 (0.33) MEN1KMT2AEPAS1CA1CA2
SCHEMBL7599616 0.78 RXRA (0.47) ALDH1A1MEN1KMT2AEPAS1KDM4E
SCHEMBL16737197 0.78 ALDH1A1 (0.61) ALDH1A1MEN1KMT2AMRGPRX4KDM4E
SCHEMBL8004806 0.78 CA12 (0.39) ALDH1A1TSHRL3MBTL1EPAS1MAPT
SCHEMBL31265222 0.75 PTGS2 (0.43) ALDH1A1KMT2AEPAS1KDM4EMAPT
SCHEMBL5599422 0.75 PTGS2 (0.43) ALDH1A1KMT2AEPAS1KDM4EMAPT
SCHEMBL2269588 0.75 PDE2A (0.43) ALDH1A1MEN1TSHRKMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1154993-B1 THIOAMIDE DERIVATIVES HOFFMANN LA ROCHE (CH) 2004-10-06 EP disclosed
US-6479666-B2 ANTIINFLAMMATORY AGENTS HOFFMAN-LA ROCHE INC. 2002-11-12 US disclosed
US-6458844-B2 ANTIINFLAMMATORY AGENTS HOFFMANN-LA ROCHE INC. 2002-10-01 US disclosed
US-6426348-B1 FOR THERAPY OF INFLAMMATION ASSOCIATED WITH CHRONIC INFLAMMATORY DISEASES SUCH AS RHEUMATOID ARTHRITIS (RA), MULTIPLE SCLEROSIS, (MS), ASTHMA, AND INFLAMMATORY BOWEL DISEASE (I BD) HOFFMANN-LA ROCHE INC. 2002-07-30 US disclosed
US-6423728-B1 INHIBIT BINDING OF VASCULAR CELL ADHESION MOLECULE-1 (VCAM-1) TO THE INTEGRIN VLA-4; USE AS ANTIINFLAMMATORY AGENTS AGAINST RHEMATOID ARTHRITIS, MULTIPLE SCLEROSIS, INFLAMMATORY BOWEL DISEASE AND ASTHMA HOFFMAN-LA ROCHE INC. 2002-07-23 US disclosed
US-20020052508-A1 Heterocyclic thioamide derivatives HULL KENNETH G (US) 2002-05-02 US disclosed
US-20020040148-A1 Diphenyl heterocyclic thioamide derivatives HULL KENNETH G (US) 2002-04-04 US disclosed
CN-1342140-A Thioamide derivatives HOFFMANN LA ROCHE (CH) 2002-03-27 CN disclosed
US-20020028933-A1 Thioamide derivatives HULL KENNETH GREGORY (US) 2002-03-07 US disclosed
US-20020010338-A1 PHENYL-KETO-IMIDAZOLIDINE THIOAMIDE DERIVATIVES HULL KENNETH G (US) 2002-01-24 US disclosed
EP-1154993-A1 THIOAMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2001-11-21 EP disclosed
US-20010041799-A1 Diephenyl carbocyclic thioamide derivatives HULL KENNETH G (US) 2001-11-15 US disclosed
US-6288267-B1 AROMATIC CARBOXY THIOAMIDES WITH AMIDES AS DRUGS TO COUNTERACT INFLAMMATION HOFFMANN-LA ROCHE INC. 2001-09-11 US disclosed
WO-2000048994-A1 THIOAMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2000-08-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020028933-A1 Thioamide derivatives VCAM1, ICAM1, LTB4R ALDH1A1 153/4885MEN1 4163/4885TSHR 706/4885
US-20020010338-A1 PHENYL-KETO-IMIDAZOLIDINE THIOAMIDE DERIVATIVES VCAM1, ICAM1, KCNA4 ALDH1A1 243/4885MEN1 4461/4885TSHR 1614/4885
US-20020040148-A1 Diphenyl heterocyclic thioamide derivatives VCAM1, ICAM1, LTB4R ALDH1A1 118/4885MEN1 4244/4885TSHR 944/4885
US-20010041799-A1 Diephenyl carbocyclic thioamide derivatives VCAM1, ICAM1, LTB4R ALDH1A1 232/4885MEN1 4115/4885TSHR 778/4885
US-20020052508-A1 Heterocyclic thioamide derivatives VCAM1, ICAM1, LTB4R ALDH1A1 153/4885MEN1 3815/4885TSHR 797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.